Creative CommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. This study examined the influence of osteoprotegerin (OPG) gene transfer on a murine collagen-induced arthritis model. A single periarticular injection of AAV-OPG or AAV-LacZ on the arthritic paw successfully incorporated the exogenous gene to the local tissue and resulted in marked transgene expression in the joint homogenate for at least three weeks. Clinical disease scores were significantly improved in OPG treated mice starting at 28-day post-treatment
ABSTRACT: Osteoprotegerin (OPG) is a secreted glycoprotein that regulates bone resorption by inhibit...
Gene therapy for the treatment of arthritis is developing rapidly. The ability to deliver genes to l...
Osteosarcoma is the most frequent primary bone tumor that develops mainly in the young, the median a...
Copyright © 2013 Qingguo Zhang et al.This is an open access article distributed under the Creative C...
Click on the DOI link to access this articleUsing an in vivo adeno-associated virus (AAV)-mediated g...
Copyright © 2013 Ying Wu et al.This is an open access article distributed under the Creative Commons...
Click on the DOI link to access the publishers version of this article (may not be free) or click on...
Exogenous OPG gene modification appears a therapeutic strategy for osteolytic aseptic loosening. The...
Osteoprotegerin (OPG) plays a determinant role in regulating bone metabolism, but the effect of OPG ...
Item does not contain fulltextEvidence from animal models convincingly supports the fact that gene t...
Gene therapy offers a radically different approach to the treatment of arthritis. We demonstrated th...
Contains fulltext : 134336.pdf (publisher's version ) (Closed access)OBJECTIVE: To...
Degenerative disease of osteoarthritis (OA) may be caused by untreated injury or trauma to articular...
Copyright © 2014 Sayuri Yoshimura et al. This is an open access article distributed under the Creati...
Objective The objective of this study was to investigate the effects of osteoprotegerin (OPG) gene ...
ABSTRACT: Osteoprotegerin (OPG) is a secreted glycoprotein that regulates bone resorption by inhibit...
Gene therapy for the treatment of arthritis is developing rapidly. The ability to deliver genes to l...
Osteosarcoma is the most frequent primary bone tumor that develops mainly in the young, the median a...
Copyright © 2013 Qingguo Zhang et al.This is an open access article distributed under the Creative C...
Click on the DOI link to access this articleUsing an in vivo adeno-associated virus (AAV)-mediated g...
Copyright © 2013 Ying Wu et al.This is an open access article distributed under the Creative Commons...
Click on the DOI link to access the publishers version of this article (may not be free) or click on...
Exogenous OPG gene modification appears a therapeutic strategy for osteolytic aseptic loosening. The...
Osteoprotegerin (OPG) plays a determinant role in regulating bone metabolism, but the effect of OPG ...
Item does not contain fulltextEvidence from animal models convincingly supports the fact that gene t...
Gene therapy offers a radically different approach to the treatment of arthritis. We demonstrated th...
Contains fulltext : 134336.pdf (publisher's version ) (Closed access)OBJECTIVE: To...
Degenerative disease of osteoarthritis (OA) may be caused by untreated injury or trauma to articular...
Copyright © 2014 Sayuri Yoshimura et al. This is an open access article distributed under the Creati...
Objective The objective of this study was to investigate the effects of osteoprotegerin (OPG) gene ...
ABSTRACT: Osteoprotegerin (OPG) is a secreted glycoprotein that regulates bone resorption by inhibit...
Gene therapy for the treatment of arthritis is developing rapidly. The ability to deliver genes to l...
Osteosarcoma is the most frequent primary bone tumor that develops mainly in the young, the median a...